The 14th edition of the Maudsley Prescribing Guidelines is available NOW
Also available to pre-order from Amazon
The Guidelines have grown somewhat organically since they were first produced as a 14 page pamphlet in 1994. For this edition we have updated all sections using published information available to us up to March 2021. New sections include ketamine formulations, intramuscular clozapine, penfluridol weekly, psychotropic discontinuation schedules and psychotropics at the end of life.
The Guidelines originated as a local document and gradually grew in size and scope into a reference used throughout the UK. More recent editions have been translated into several languages, including Japanese and Chinese, and The Guidelines have seen increased use in other English-speaking countries, particularly the USA. Because of this we have tried more than ever in this edition to make The Guidelines of worldwide relevance by including advice on the use of a range of psychotropics commonly prescribed in countries outside the UK in 2021.
David M. Taylor BSc, MSc, PhD, FRCP(Edin), FRCPsych(Hon), FFRPS, FRPharmS, is Director of Pharmacy and Pathology at the Maudsley Hospital and Professor of Psychopharmacology at King’s College, London.
Thomas R. E. Barnes, MBBS, MD, FRCPsych, DSc, is Emeritus Professor of Clinical Psychiatry at Imperial College London and joint-head of the Prescribing Observatory for Mental Health at the Royal College of Psychiatrists’ Centre for Quality Improvement.
Allan H. Young, MB, ChB, MPhil, PhD, FRCP, FRCPsych, is Chair of Mood Disorders and is Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry at King’s College London, UK.